CGNX · NASDAQ
Cognex (CGNX) Stock Price & Fundamentals
Cognex (CGNX) closed at $645.12 on Oct 9, 2026, up 0.84% from the previous close of $639.75.
Share price, past year
1Y −16.18%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $645.12 |
| Sep 30, 2026 | $646.31 |
| Aug 31, 2026 | $643.01 |
| Jul 31, 2026 | $712.91 |
| Jun 30, 2026 | $690.14 |
| May 29, 2026 | $714.51 |
| Apr 30, 2026 | $719.02 |
| Mar 31, 2026 | $763.11 |
| Feb 27, 2026 | $784.10 |
| Jan 30, 2026 | $765.59 |
| Dec 31, 2025 | $754.83 |
| Nov 28, 2025 | $744.12 |
| Oct 31, 2025 | $787.25 |
Key statistics
- Market cap
- $108.52B
- P/E (TTM)
- 620.3
- EPS (TTM)
- $1.04
- Revenue (TTM)
- $1.09B
- Net income (TTM)
- $174.79M
- Shares outstanding
- 168.2M
- Dividend yield
- —
- 52-week range
- $636.25 – $805.76
Cognex's market cap is $108.52B, based on a share price of $645.12 and 168.2M shares outstanding as of Jul 5, 2026.
Financials
Cognex reported revenue of $994.36M for fiscal 2025, up 8.73% from fiscal 2024.
Cognex earned net income of $114.44M in fiscal 2025, a net margin of 11.5%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $994.36M | +8.7% | $114.44M | 11.5% | $0.68 | $236.77M |
| FY2024ended Dec 31, 2024 | $914.52M | +9.2% | $106.17M | 11.6% | $0.62 | $134.04M |
| FY2023ended Dec 31, 2023 | $837.55M | −16.8% | $113.23M | 13.5% | $0.65 | $89.84M |
| FY2022ended Dec 31, 2022 | $1.01B | −3.0% | $215.53M | 21.4% | $1.23 | $223.74M |
| FY2021ended Dec 31, 2021 | $1.04B | +27.9% | $279.88M | 27.0% | $1.56 | $298.61M |
| FY2020ended Dec 31, 2020 | $811.02M | +11.8% | $176.19M | 21.7% | $1.00 | $229.10M |
| FY2019ended Dec 31, 2019 | $725.63M | −10.0% | $203.87M | 28.1% | $1.16 | $231.57M |
| FY2018ended Dec 31, 2018 | $806.34M | +5.3% | $219.27M | 27.2% | $1.24 | $186.36M |
| FY2017ended Dec 31, 2017 | $766.08M | +44.7% | $176.71M | 23.1% | $0.98 | $195.57M |
| FY2016ended Dec 31, 2016 | $529.52M | — | $143.69M | 27.1% | $0.415 | $169.27M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jul 5, 2026 | $291.26M | $72.76M | $0.43 |
| Q1 FY2026ended Apr 5, 2026 | $268.44M | $51.70M | $0.31 |
| Q4 FY2025ended Dec 31, 2025 | $252.34M | $32.66M | $0.20 |
| Q3 FY2025ended Sep 28, 2025 | $276.89M | $17.66M | $0.10 |
| Q2 FY2025ended Jun 29, 2025 | $249.09M | $40.51M | $0.24 |
| Q1 FY2025ended Mar 30, 2025 | $216.04M | $23.60M | $0.14 |
| Q4 FY2024ended Dec 31, 2024 | $229.68M | $28.35M | $0.17 |
| Q3 FY2024ended Sep 29, 2024 | $234.74M | $29.59M | $0.17 |
Company profile
- Name
- Cognex Corporation
- Ticker
- CGNX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Industrial Instruments For Measurement, Display, and Control
- Headquarters
- One Vision Dr, Natick, MA 01760
- Incorporated in
- MA
- Fiscal year ends
- December
- SEC CIK
- 0000851205
Recent SEC filings
- Sep 22, 2026
- Aug 6, 2026
- Aug 5, 2026
- May 7, 2026
- May 6, 2026
- Apr 30, 2026
- Feb 17, 2026
- Feb 12, 2026
Frequently asked questions
What is Cognex's stock price?
Cognex (CGNX) closed at $645.12 on Oct 9, 2026, up 0.84% from the previous close of $639.75.
What is Cognex's market cap?
Cognex's market cap is $108.52B, based on a share price of $645.12 and 168.2M shares outstanding as of Jul 5, 2026.
How much revenue does Cognex make?
Cognex reported revenue of $994.36M for fiscal 2025, up 8.73% from fiscal 2024.
What is CGNX's P/E ratio?
Cognex's price-to-earnings ratio is 620.3, based on trailing twelve-month diluted EPS of $1.04.
Does Cognex pay a dividend?
Cognex's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cognex Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures